Novartis
A Senior Scientist II in Chemical Biology at Novartis will design and execute innovative strategies to explore emerging modalities like induced proximity and validate key mechanisms of action for early-stage drug discovery. The role involves generating high-quality data, developing cellular assays, and integrating multi-omics workflows to support the advancement of candidates into the therapeutic pipeline alongside cross-functional partners. Success requires strong hands-on expertise in molecular and cellular biology combined with creative experimental design and interpretation of complex biological datasets.
Headquarters
Basel, Basel-Stadt, Switzerland
Company Size
10001+ employees
Founded
1996
Novartis is an innovative medicines company that pursues scientific breakthroughs to improve and extend people's lives. The company develops and delivers medicines across therapeutic areas including cardiovascular, immunology, neuroscience, and oncology, with its treatments reaching 296 million patients worldwide. With more than 250 years of heritage and 30 years as Novartis, the company works to turn innovations into medicines that redefine the future for patients.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Novartis.
Right around the average for this role
Senior Principal Scientist – Chemical Biology & Proximity-Based Therapeutics
lifelancer
R-251294 Principal Scientist – Chemical Biology & Proximity-Based Therapeutics
Amgen
Scientist, Induced Proximity Drug Discovery
Birdwood Therapeutics
Scientist
Eli Lilly and Company
ASSISTANT PROFESSOR POSITION IN MOLECULAR SYSTEMS BIOLOGY
University of Tennessee, Knoxville
Postdoctoral Fellow
Salk Institute